Results 91 to 100 of about 13,710 (215)
The levonorgestrel-releasing intrauterine system: Safety, efficacy, and patient acceptability
, 2009 Megan N Beatty, Paul D BlumenthalDepartment of Obstetrics and Gynecology, Stanford University, Stanford, CA, USAAbstract: The levonorgestrel-releasing intrauterine system (LNG-IUS) is a safe, effective and acceptable form of contraception used by over ...
Megan N Beatty, Paul D Blumenthal
core
Effects of Levonorgestrel On Breast Cancer Cell Proliferation
, 2022 UndergraduateBreast cancer is the leading type of cancer in the U.S. among women and the second leading cause of cancer-related deaths. Women who are exposed to external hormones, through contraceptives and hormone replacement therapy, have been shown to
Berry, Sophia
core
Journal of Health Science and Medical Research (JHSMR)Objective: This study used female Wistar rats to evaluate the impact of incessant intake of levonorgestrel on liver function and integrity, and to observe the effect of drug withdrawal on the organs. (organ).
Catherine Adeniji +4 more
doaj +1 more source
International Journal of Gynecology &Obstetrics, Volume 174, Issue 3, Page 1151-1171, September 2026.Abstract Recent advances in cancer screening, diagnosis, and treatment have greatly improved survival rates among women with gynecologic cancers. More survivors now live long enough to experience treatment‐related menopause. Vasomotor symptoms, genitourinary syndrome of menopause, sexual dysfunction, sleep issues, and long‐term risks from estrogen ...
Agnaldo Lopes da Silva‐Filho +8 more
wiley +1 more source
, 2011 Shirin Ghazizadeh1, Fatemeh Bakhtiari1, Haleh Rahmanpour2, Fatemeh Davari-Tanha1, Fatemeh Ramezanzadeh11Valie-Asr Reproductive Health Research Center, Valie-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran; 2Department of Obstetrics and ...
Davari-Tanha F +4 more
core
Peri‐ and Post‐Menopausal Hormone Replacement Therapy and Voice Disorder Risk: A TriNetX Study
The Laryngoscope, Volume 136, Issue 9, Page 3859-3865, September 2026.ABSTRACT Objectives The aim of this study was to elucidate the risk of developing voice disorders among peri‐ and post‐menopausal female hormone replacement therapy (HRT) users. Methods A retrospective cohort study was conducted using the TriNetX Global Collaborative Network.
David Kayekjian +4 more
wiley +1 more source
, 2002 Background: A single 10 mg dose of mifepristone, and two 0.75 mg doses of levonorgestrel 12 h apart, are effective for emergency contraception. Because no studies had compared the efficacies of both compounds, or investigated a single dose of 1.5 mg ...
Ng, E +17 more
core +1 more source
Individualization of approaches to managing patients during menopausal transition
Репродуктивная эндокринология, 2018 The global aging of the population leads to a significant increase in the demographic burden on society, puts a heavy burden on the economy and causes significant structural changes in the sphere of social security.
Т. Ф Татарчук +5 more
doaj +1 more source
Pharmacoepidemiology and Drug Safety, Volume 35, Issue 9, September 2026.ABSTRACT Background In pharmacoepidemiologic research, correct assignment of the length of single dispensation is critical to build treatment episodes. The parametric reverse waiting time distribution (rWTD) is a particularly attractive data‐driven method to estimate dispensation lengths.
Mette Reilev +8 more
wiley +1 more source
The levonorgestrel intrauterine system: Long-term contraception and therapeutic effects
, 2005 The levonorgestrel intrauterine system (Mirena®) has been developed as a long-acting method of contraception. This medicated device, inserted into the uterus, delivers a small daily dose of a progestin, levonorgestrel, into the uterine cavity.
Inki, Pirjo, Sitruk-Ware, Régine
core +1 more source